IGF1R and glioblastoma: Numerous studies have demonstrated that impeding IGF-1R by inhibitors or monoclonal antibodies curtails the expansion and invasion of tumor cells, augments apoptosis, and heightens the vulnerability of GBM cells to chemotherapy and radiation.